Search

everythinglearnresearchcommunity

for

Search:↓

In Spain, dermatologists most commonly prescribe topical minoxidil and oral finasteride for male hair loss, and topical minoxidil and oral contraceptives for female hair loss. The use of oral dutasteride and oral minoxidil has significantly increased over the past three years.

Hair ages due to various factors and treatments like minoxidil and finasteride can help, but more research and better public awareness are needed.

Finasteride effectively treats hair loss and enlarged prostate in men, with mild side effects.

Identifying nonclassic congenital adrenal hyperplasia and carriers of CYP21 mutations is challenging, and genetic counseling is recommended due to their prevalence.

Female pattern hair loss involves thinning hair on crown and frontal scalp, diagnosed by hair ratio, and treated with minoxidil, antiandrogens, or hair transplantation.

Oral lichen planus is not linked to sex hormone levels.

The document concludes that more research is needed to include new treatments in guidelines for Polycystic Ovary Syndrome (PCOS).

The document concludes that scalp conditions have various causes and can present in many different ways.

AKR1C3 could be a treatment target for metabolic issues in PCOS.

The document concludes that treatments for female hair loss and excess body hair are available, but managing expectations is important.

Healthy aging can be promoted through physical activity, lifestyle changes, and certain treatments.

Pattern baldness is likely caused by a dominant gene influenced by testosterone levels, making it more common in men.

Cosmetic hair treatments can increase hair testosterone levels, while natural hair color does not affect it.

Androgens significantly affect female hair loss, and hormonal treatments may help.

Female pattern hair loss diagnosis is challenging and should use dermoscopy and histopathology instead of pattern recognition, as hormones may not always be the cause.

Eating healthy and exercising can help manage Polycystic Ovarian Syndrome and its related health problems.

The document concludes that managing skin conditions during pregnancy is important and requires specialized care.

The conclusion is that PCOS is caused by ovarian sensitivity to hormones and disrupted hormone control, possibly due to ovarian factors, and more research is needed.

The document concludes that proper diagnosis and FDA-approved treatments for different types of hair loss exist, but treatments for severe cases often fail and future improvements may focus on hair follicle stem cells.

Oestrogen and thyrotropin-releasing hormone affect prolactin and its receptor in human skin and hair, suggesting new treatment options for related conditions.

DHT's role in hair loss is important, but measuring its level for diagnosis is questionable.

The study concluded that both estrogen and androgen receptors, which decrease with age, are linked to skin aging and may be hormonally regulated.

Spironolactone is a low-cost, effective, and generally safe treatment for various skin conditions related to hormones.

Chemotherapy patients don't all lose their hair due to factors like hair growth rates, age, genetics, and the type of drugs used.

Venous catheterization may help diagnose the cause of female hyperandrogenism when imaging is unclear.

Gender affects hair and scalp characteristics, with differences in hormone responses, graying patterns, and trace metals.

Platelet Rich Plasma can potentially help in restoring hair loss, but more research with larger groups is needed to confirm its effectiveness and standardize its use.

The European Society of Endocrinology advises individualized long-term management for PCOS, focusing on lifestyle changes, accurate diagnosis, and treatments for associated health risks and symptoms.

The article suggests managing interferon beta therapy side effects in MS with dose adjustments, medications, and patient education.

The spiny mouse is a unique menstruating rodent that can help us understand menstruation and reproductive disorders.